The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s HyperImmune Globulins Global Market Report 2024, the hyperImmune globulins market is expected to show significant growth in the forecast period.

The hyperimmune globulins market has experienced significant growth recently and is poised for continued expansion. Below is an overview of the current market dynamics and future trends.

Market Overview

• Current Market Size: The market reached $1.78 billion in 2023.
• Projected Growth: Expected to grow to $1.91 billion in 2024.
• Compound Annual Growth Rate (CAGR): 7.5% for 2023-2024.

Drivers of Growth:

• Increased Government Support: Enhanced funding and policy support.
• Rising Healthcare Expenditures: Increased investments in healthcare services.
• High Prevalence of Diseases: Notable cases of hepatitis B and rabies.
• Awareness of Zoonotic Diseases: Growing public awareness about diseases transmitted from animals.
• Aging Population: Increased demand due to a growing geriatric demographic.

Future Outlook

• Forecast Market Size: Expected to reach $2.57 billion by 2028.
• Forecast CAGR: 7.7% from 2024 to 2028.

View More On The HyperImmune Globulins Market Report 2024 – https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Key Growth Factors:

• Infectious Disease Prevalence: Increasing rates of diseases such as hepatitis B.
• Awareness and Demand: Growing knowledge about hyperimmune globulin benefits.
• Immunoglobulin Demand: Rising need for immune system support.
• Alpha-1 Antitrypsin Deficiency: Increasing cases driving demand.
• Immune Deficiencies: Rising incidences boosting market needs.

Major Trends:

• Technological Advancements: Innovations in treatment and manufacturing.
• Investment in R&D: Growing funding for research and development.
• Passive Immunity Treatments: Increased focus on treatments that provide immediate immune protection.
• Advancements in Plasma-Derived Therapies: Enhanced methods for producing hyperimmune globulins.

Rising Infectious Disease Prevalence

• Infectious Diseases: Caused by pathogens such as viruses, bacteria, fungi, and parasites.
• Market Impact: Growing prevalence of these diseases is driving demand for hyperimmune globulins.
• Case Example: Increase in chronic hepatitis B cases in the US from 14,229 in 2021 to 16,729 in 2022.

Hyperimmune Globulin Usage:

• Preventive and Therapeutic: Used for diseases like rabies, hepatitis B, and tetanus.
• Immediate Passive Immunity: Provides rapid protection by delivering concentrated antibodies.

Key Players and Recent Developments

• Leading Companies: F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., and others.
• Recent Acquisition: Grifols S.A. acquired Biotest in April 2022 to expand its plasma therapy portfolio and enhance its European presence.

Grifols’ Expansion:

• Acquisition Details: Biotest, a Germany-based biotechnology company, adds to Grifols’ capabilities.
• Network Growth: Addition of 87 plasma centers across Europe.
• Strategic Goals: Revenue growth and improved market share.

Market Segmentation

• By Type:
  • Hepatitis B Hyperimmune Globulin
  • Rabies Hyperimmune Globulin
  • Tetanus Hyperimmune Globulin
  • Cytomegalovirus (CMV) Hyperimmune Globulin
  • Varicella-Zoster Virus (VZV) Hyperimmune Globulin
  • Respiratory Syncytial Virus (RSV) Hyperimmune Globulin
  • Other Types
• By Route of Administration:
  • Intramuscular
  • Intravenous
• By Application:
  • Government Institutions
  • Private Sector
  • Other Applications

Regional Insights

• North America: The largest market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

The hyperimmune globulins market is set for robust growth due to increasing disease prevalence, technological advancements, and rising awareness. This upward trajectory highlights the critical role of these treatments in managing and preventing infectious diseases globally.

Request A Sample Of The Global HyperImmune Globulins Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16448&type=smp